HIV, AIDS, and STDs Category

Challenges Facing a Rural Opioid Epidemic-Treatment and Prevention of HIV and Hepatitis C

1.5 CE Hour
601 members have taken this course

About the Course

This course addresses challenges facing a rural opioid epidemic for the treatment and prevention of HIV and Hepatitis C. This course includes: current epidemiological trends in HIV and HCV among PWID, barriers that prevent rural PWID from accessing HIV and HCV testing and treatment, the efficacy of HIV and HCV treatment among PWID, optimizing HIV and HCV treatment outcomes among PWID, current best practices in HIV and HCV prevention among PWID, and Learning from Scott County, Indiana: Addressing Risks in Ohio and North Carolina.

This course is based on the article,Challenges Facing a Rural Opioid Epidemic-Treatment and Prevention of HIV and Hepatitis C created by Asher J. Schranz, MD, et al. in 2018.

Publication Details

Publication Date: 2018

Course Material Authors

Course Material Authors authored the material only, and were not involved in creating this CE course. They are identified here for your own evaluation of the relevancy of the material this course is based on.

Asher J. Schranz, MD
Dr. Asher Schranz is an infectious disease specialist in Chapel Hill, North Carolina. Dr. Schranz’s clinical interests include endovascular infections, viral hepatitis and HIV. He is also interested in caring for infectious diseases in persons with substance use disorders. His research is broadly focused on the intersection of infectious diseases and substance use disorders. He utilizes large datasets to study invasive infections – such as infective endocarditis and bone, joint and spine infections – affecting people who inject drugs, in both North Carolina and the US.
Jessica Barrett, DO
Dr. Jessica L. Barrett is an infectious disease specialist in Columbus, Ohio and is affiliated with Ohio Health Riverside Methodist Hospital.
Christopher B. Hurt, MD
Christopher B. Hurt, MD is an Assistant Professor of Medicine in the Institute for Global Health & Infectious Diseases, University of North Carolina at Chapel Hill. Dr. Hurt serves as an investigator with the UNC Global HIV Prevention and Treatment Clinical Trials Unit, overseeing clinical trials in HIV pre-exposure prophylaxis (PrEP) and hepatitis C. Dr. Hurt’s research is focused on the behavioral epidemiology of HIV – specifically with an interest in understanding the structural and behavioral factors that influence the spread of HIV among men who have sex with men (MSM) of color in the Southeastern United States.

Course Creator

L.A. Rankin

L.A. Rankin is a social worker with experience in many different settings with a variety of clients. She has worked with dementia and Alzheimers patients, dual diagnosis MH/MR, in a battered women’s shelter, and a rape crisis center. She also has 11 years of experience as a child protective social worker, where she earned certificates in domestic abuse/family violence and substance abuse.

Target Audience

Counselors, marriage and family therapists, psychologists and social workers. This course is appropriate for all levels of knowledge.

Learning Objectives

After taking this course, you should be able to:

  1. 1 Acknowledge the rural opioid epidemic has led to the spread of HIV and Hepatitis C.
  2. 2 Identify the barriers to preventing and treatment.
  3. 3 Summarize the method to best treat and prevent HIV and Hepatitis C.

Disclosure to Learners

CE Learning Systems adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CE activity – including faculty, planners, reviewers, or others ― are required to disclose all relevant financial relationships with ineligible entities (formerly known as commercial interests).

The following relevant financial relationships have been disclosed by this activity's planners, faculty, and the reviewer:

Planners and Reviewers

The planners of this activity have reported that they have no relevant financial relationships.

Material Authors

Any relevant financial disclosures for course material authors can be found in the article.

Course Creator

L.A. Rankin – There are no relevant disclosures.

Commercial support

There is no commercial support for this distance-learning course.

$13.50

Course Details

1.5 CE Hours
Reading Online
Course 102698

Availability

This course is available until Jan 4th, 2038.

Frequently Asked Questions

Frequently Asked Questions

Yes, most likely. Look Up Your State Board for more detailed information. Logged-in site members will see the relevant approval information displayed in the Approvals tab for every course.

If you are having trouble using Impact CE, please contact us! We would be happy to accommodate your needs right away, and your input will help us make Impact CE more accessible for future users too.

Use the Enroll In This Course button and just follow the instructions! You don't pay anything until you're ready to take an exam.

To complete the course, review the course objectives, then review the material, and then pass the exam with a score of 75% or greater and lastly complete an evaluation.

Most of our self-paced courses are based on online articles available for free to the public. Some courses, such as those based on books, require that you purchase the material. Use the Materials tab for more info. Live courses simply require that you attend.

Your certificate(s) will be available to download or email immediately when you pass the course exam and complete the evaluation.

Yes! Use the Help widget at the bottom-right of the screen anywhere on Impact CE to search our help docs, or to ask our support team for help. Unlike most of our competitors, Impact CE has live US-based support reps to help you by email, chat, or phone.

Start your CE Journey now - complete your first course today, on us.

Try for free - no commitment required.

Continuing Education

Confirm Action